UK MHRA approves Serum Life Science Europe’s Anktiva to treat adult patients with non-muscle invasive bladder cancer: United Kingdom Monday, July 7, 2025, 12:00 Hrs [IST] The UK ...

CG Oncology, Inc. (NASDAQ:CGON) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 17, ...

UroGen Pharma Ltd. (NASDAQ: URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen ...

Second-look TURBT showed limited value in altering outcomes for high-grade Ta bladder cancer after complete resection.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

(Alliance News) - AstraZeneca PLC on Friday said Imfinzi is "poised to transform the standard of care" as it reported the bladder cancer treatment cleared a European regulatory milestone.

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.

Joseph Jacob, MD, discusses the promising impact of TAR-200.

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia ...

As Assistant Nurse Manager, Her Role Is to Be a Support Person Kara Lombardi traces her interest in healthcare, and the ...